IvanVogelius
@ivanvogelius.bsky.social
Professor and head of medical physics, dept of Oncology, Rigshospitalet, Denmark
Its easier to avoid one country’s products than going up against them all. Most stuff can just be bought from somewhere else
March 17, 2025 at 8:47 PM
Its easier to avoid one country’s products than going up against them all. Most stuff can just be bought from somewhere else
Reposted by IvanVogelius
Remember the misleading press about "brutal" #radonc after PROSPECT ?
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
December 15, 2024 at 9:23 PM
Remember the misleading press about "brutal" #radonc after PROSPECT ?
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
Reposted by IvanVogelius
In case you may have missed any of the
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
December 5, 2024 at 2:12 PM
In case you may have missed any of the
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
Reposted by IvanVogelius
Four brilliant days in Vienna - with a super engaged multidisciplinary group of participant 🤩 #radonc #medphys
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
December 4, 2024 at 8:32 PM
Four brilliant days in Vienna - with a super engaged multidisciplinary group of participant 🤩 #radonc #medphys
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
Reposted by IvanVogelius
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
There are already many articles for which there is more attention on Bluesky than on other comparable micro-blogging sites, meaning the academic community and the general public have clearly adopted Bluesky as one of its core places to disseminate and discuss new research.
A Place of Joy.
A Place of Joy.
December 3, 2024 at 2:10 PM
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
Reposted by IvanVogelius
Introducing the new "NOPE" algorithm
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
December 2, 2024 at 3:01 PM
Introducing the new "NOPE" algorithm
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
Getting ready for day two of ESTRO quantitative methods course. Fantastic group and engaged faculty. Here @cdfuller.bsky.social as a force of nature on “data sharing how and why”
December 2, 2024 at 7:05 AM
Getting ready for day two of ESTRO quantitative methods course. Fantastic group and engaged faculty. Here @cdfuller.bsky.social as a force of nature on “data sharing how and why”
Reposted by IvanVogelius
Virtual Grand Rounds in Radiation Oncology
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
November 28, 2024 at 9:17 AM
Virtual Grand Rounds in Radiation Oncology
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
99 of 100 patients included this week...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
ClinicalTrials.gov
ClinicalTrials.gov
November 29, 2024 at 7:43 AM
99 of 100 patients included this week...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
November 23, 2024 at 10:26 AM
First real post: #job
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
www.regionh.dk
November 19, 2024 at 10:00 PM
First real post: #job
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
Happy to join Bluesky. Let’s see what this brings. I hope to use it for a solid human curated interaction on news in radiotherapy and oncology. Like twitter used to be, just better :-)
November 19, 2024 at 9:59 PM
Happy to join Bluesky. Let’s see what this brings. I hope to use it for a solid human curated interaction on news in radiotherapy and oncology. Like twitter used to be, just better :-)